Background
==========

To determine the mechanism by which HIV infection alters the expression and activity of CATB and its inhibitor, cystatin B (CSTB).

Methods
=======

Peripheral blood derived macrophages (MDM) were infected with HIV~ADA~at a MOI of 0.1 and cultured for up to 12 days. Intracellular and extracellular expression of CATB, CST B and CSTC in uninfected and HIV-infected cells were analyzed by Western blots and ELISA at 6, 9 and 12 days post infection (days p.i.). Activity of CAT B after HIV infection was determined by fluorescence and confocal microscopy.

Results
=======

Expression of CATB protein and its intracellular inhibitor, CSTB, was increased in HIV infected cells after 12 days p.i. compared to uninfected controls (p =\< 0.05). However CSTC increase was not significant in HIV infected cells. CATB was secreted to similar (\>400 ng/ml) levels in both HIV-infected and uninfected cells at higher levels than those proved by others to promote cell damage (100 ng/ml or more). Importantly, secreted CATB from HIV-infected MDMs was significantly (p= 0.008) more active than that secreted from control cells throughout the extent of the infection.

Discussion
==========

HIV infection increases the levels of active CATB in supernatants 4 times higher than those previously reported by other groups to be toxic to neuronal cells. Although CSTB increased in HIV-infected cultures, no effective inhibition of CATB was seen at 12 days pot-infection. Our results suggest that HIV infection is capable of altering the interactions between CATB and its inhibitors promoting, an increase in active CATB secretion, which may contribute to neuronal damage.
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